We support bold science, backed by patients, to keep our research both cutting-edge and relevant. Patients give feedback directly to scientists so that they can understand, learn and modify their research so that what they do in a lab will make a difference to patients.
Over the past four years, we have expanded our research five-fold, notwithstanding the COVID-19 pandemics and lockdowns, in which we were the only charity not to cut a single research project or budget, and been shortlisted for an impact award. We are endlessly striving for patient benefit. Having expanded so exponentially in the UK, we are now launching in the US so that even more people affected by prostate cancer can benefit from what we do and so that we can bring the brightest minds on both sides of the Atlantic together to accelerate innovation.